Liquid Biopsy And Other Non-invasive Cancer Diagnostics Market, Forecast To 2030

By Author: Stella Wilson
Total Articles: 45
Comment this article

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.

The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across the following segments:

Type of Tumor Marker
• ctDNA
• cfDNA
• CTCs
• Exosomes
• Others

Application
• Diagnosis / Early Diagnosis
• Patient Monitoring
• Recurrence Monitoring

Target Cancer Indication
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Bladder Cancer
• Melanoma
• Gastric Cancer
• Pancreatic Cancer
• Ovarian Cancer
• Others

End Users
• Hospitals
• Research Institutes
• Others

Key Geographical Regions
• North America
• Europe
• Asia-Pacific
• Rest of the World

Request for Sample: ...
... https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html

The Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers report features the following companies, which we identified to be key players in this domain:

Key Players:
• Amoy Diagnostics
• DiaCarta
• HaploX Biotechnology
• NeoGenomics
• QIAGEN
• Swift Biosciences
• Sysmex Inostics
• Thermo Fisher Scientific

Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Non-Invasive Cancer Screening and Diagnosis
5. Market Landscape
6. Company Profiles
7. Partnerships and Collaborations
8. Funding and Investment Analysis
9. Liquid Biopsy: Initiatives of Big Pharma Players
10. Key Acquisition Targets
11. Other Non-Invasive Cancer Diagnostics
12. Market Sizing and Opportunity Analysis
13. Survey Insights
14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com